Vericel (VCEL) Asset Writedowns and Impairment (2014 - 2026)
Vericel's (VCEL) quarterly Asset Writedowns and Impairment came in at $173000.0 in Q1 2026, up 157.1% quarter-over-quarter from -$303000.0 in Q4 2018.
Vericel (VCEL) Asset Writedowns and Impairment (2014 - 2026) Analysis & Trends
Vericel has disclosed Asset Writedowns and Impairment across 6 years of filings, most recently posting $173000.0 for Q1 2026.
- Asset Writedowns and Impairment for Q1 2026 came in at $173000.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $407000.0 (up 332.98% YoY), and the FY2025 annual result was $1.0 million, changed N/A from the prior year.
- Asset Writedowns and Impairment came in at $173000.0 for Q1 2026 at Vericel, up from -$303000.0 in the prior quarter.
- In the past five years, Asset Writedowns and Impairment ranged from a high of $173000.0 in Q1 2026 to a low of $173000.0 in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Vericel | 2.04 Bn | 1.90 Bn | 49.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 173,000.00 |
| Mar 31, 2026 | 173,000.00 |
| Dec 31, 2018 | -303,000.00 |
| Dec 31, 2018 | -303,000.00 |
| Sep 30, 2018 | 537,000.00 |
| Sep 30, 2018 | 537,000.00 |
| Jun 30, 2018 | -140,000.00 |
| Jun 30, 2018 | -140,000.00 |
| Mar 31, 2018 | -94,000.00 |
| Mar 31, 2018 | -94,000.00 |
| Dec 31, 2017 | -232,000.00 |
| Dec 31, 2017 | -232,000.00 |
| Sep 30, 2017 | 72,000.00 |
| Sep 30, 2017 | 72,000.00 |
| Jun 30, 2017 | 67,000.00 |
| Jun 30, 2017 | 67,000.00 |
| Mar 31, 2017 | 93,000.00 |
| Mar 31, 2017 | 93,000.00 |
| Dec 31, 2016 | 2.54 Mn |
| Dec 31, 2016 | 2.54 Mn |